T1	AdverseReaction 729 739	fetal harm
T2	Factor 719 722	May
T3	AdverseReaction 897 905	Diarrhea
T4	AdverseReaction 907 913	nausea
T5	AdverseReaction 915 923	vomiting
T6	AdverseReaction 929 943	abdominal pain
T7	AdverseReaction 1591 1607	Thrombocytopenia
T8	AdverseReaction 1609 1615	anemia
T9	AdverseReaction 1620 1631	neutropenia
T10	AdverseReaction 2004 2029	drug induced liver injury
T11	AdverseReaction 2053 2070	elevations in ALT
T12	Severity 2103 2108	3*ULN
T13	AdverseReaction 2053 2066;2074 2077	elevations in AST
T14	AdverseReaction 2114 2148	total bilirubin greater than 2*ULN
T16	AdverseReaction 2153 2189	alkaline phosphatase less than 2*ULN
T18	AdverseReaction 2461 2474	ALT elevation
T19	AdverseReaction 2487 2500	AST elevation
T20	AdverseReaction 2556 2567;2582 2585	increase in AST
T21	AdverseReaction 2556 2567;2575 2578	increase in ALT
T22	AdverseReaction 2601 2624	transaminase elevations
T23	AdverseReaction 2682 2705	transaminase elevations
T24	AdverseReaction 2819 2832	increased ALT
T25	AdverseReaction 2819 2828;2837 2840	increased AST
T26	AdverseReaction 3283 3298	Fluid retention
T27	AdverseReaction 3339 3359	pericardial effusion
T28	AdverseReaction 3361 3377	pleural effusion
T29	Factor 3323 3326	may
T30	AdverseReaction 3379 3394	pulmonary edema
T31	AdverseReaction 3403 3419	peripheral edema
T32	AdverseReaction 3528 3543	fluid retention
T33	Severity 3521 3527	severe
T34	AdverseReaction 3622 3638	pleural effusion
T35	Severity 3609 3616	Grade 3
T36	Severity 3609 3614;3620 3621	Grade 4
T37	AdverseReaction 3687 3694;3711 3720	pleural effusions
T38	AdverseReaction 3699 3720	pericardial effusions
T39	Severity 3668 3675	Grade 3
T40	Severity 3679 3686	Grade 4
T41	Severity 3744 3751	Grade 3
T42	AdverseReaction 3752 3762;3777 3782	peripheral edema
T43	AdverseReaction 3767 3782	pulmonary edema
T44	AdverseReaction 3812 3817	edema
T45	Severity 3804 3811	Grade 3
T46	AdverseReaction 4055 4102	decline in estimated glomerular filtration rate
T59	AdverseReaction 4886 4900	Kidney Failure
T60	AdverseReaction 6436 6446	fetal harm
T61	Factor 6426 6429	can
T62	AdverseReaction 6503 6525	embryofetal toxicities
T63	Animal 6529 6536	rabbits
T64	AdverseReaction 52 77	Gastrointestinal Toxicity
T65	AdverseReaction 182 198	Myelosuppression
T66	AdverseReaction 269 285	Hepatic Toxicity
T67	AdverseReaction 438 453	Fluid Retention
T68	AdverseReaction 587 601	Renal Toxicity
T15	AdverseReaction 697 717	Embryofetal Toxicity
E1	AdverseReaction:T1 Hypothetical:E2
E2	Factor:T2
E3	AdverseReaction:T3
E4	AdverseReaction:T4
E5	AdverseReaction:T5
E6	AdverseReaction:T6
E7	AdverseReaction:T7
E8	AdverseReaction:T8
E9	AdverseReaction:T9
E10	AdverseReaction:T10
E11	AdverseReaction:T11 Effect:E12
E12	Severity:T12
E13	AdverseReaction:T13 Effect:E12
E14	AdverseReaction:T14
E16	AdverseReaction:T16
E18	AdverseReaction:T18
E19	AdverseReaction:T19
E20	AdverseReaction:T20
E21	AdverseReaction:T21
E22	AdverseReaction:T22
E23	AdverseReaction:T23
E24	AdverseReaction:T24
E25	AdverseReaction:T25
E26	AdverseReaction:T26
E27	AdverseReaction:T27 Hypothetical:E29
E28	AdverseReaction:T28 Hypothetical:E29
E29	Factor:T29
E30	AdverseReaction:T30 Hypothetical:E29
E31	AdverseReaction:T31 Hypothetical:E29
E32	AdverseReaction:T32 Effect:E33
E33	Severity:T33
E34	AdverseReaction:T34 Effect:E35 Effect2:E36
E35	Severity:T35
E36	Severity:T36
E37	AdverseReaction:T37 Effect:E39 Effect2:E40
E38	AdverseReaction:T38 Effect:E39 Effect2:E40
E39	Severity:T39
E40	Severity:T40
E41	Severity:T41
E42	AdverseReaction:T42 Effect:E41
E43	AdverseReaction:T43 Effect:E41
E44	AdverseReaction:T44 Effect:E45
E45	Severity:T45
E46	AdverseReaction:T46
E62	AdverseReaction:T59
E63	AdverseReaction:T60 Hypothetical:E64
E64	Factor:T61
E65	AdverseReaction:T62 Hypothetical:E66
E66	Animal:T63
E67	AdverseReaction:T64
E68	AdverseReaction:T65
E69	AdverseReaction:T66
E70	AdverseReaction:T67
E71	AdverseReaction:T68
E15	AdverseReaction:T15
A1	CUI E1 C0854268
A2	UMLS-Preferred-Name E1 Foetal damage
A3	MEDDRA-PT E1 Foetal damage
A4	MEDDRA-PT-ID E1 10016852
A5	LLT E1 Fetal damage
A6	LLT-ID E1 10054743
A7	CUI E3 C0011991
A8	UMLS-Preferred-Name E3 Diarrhea
A9	MEDDRA-PT E3 Diarrhoea
A10	MEDDRA-PT-ID E3 10012735
A11	LLT E3 Diarrhea
A12	LLT-ID E3 10012727
A13	CUI E4 C0027497
A14	UMLS-Preferred-Name E4 Nausea
A15	MEDDRA-PT E4 Nausea
A16	MEDDRA-PT-ID E4 10028813
A17	CUI E5 C0042963
A18	UMLS-Preferred-Name E5 Vomiting
A19	MEDDRA-PT E5 Vomiting
A20	MEDDRA-PT-ID E5 10047700
A21	CUI E6 C0000737
A22	UMLS-Preferred-Name E6 Abdominal Pain
A23	MEDDRA-PT E6 Abdominal pain
A24	MEDDRA-PT-ID E6 10000081
A25	CUI E7 C0040034
A26	UMLS-Preferred-Name E7 Thrombocytopenia
A27	MEDDRA-PT E7 Thrombocytopenia
A28	MEDDRA-PT-ID E7 10043554
A29	CUI E8 C0002871
A30	UMLS-Preferred-Name E8 Anemia
A31	MEDDRA-PT E8 Anaemia
A32	MEDDRA-PT-ID E8 10002034
A33	LLT E8 Anemia
A34	LLT-ID E8 10002272
A35	CUI E9 C0027947
A36	UMLS-Preferred-Name E9 Neutropenia
A37	MEDDRA-PT E9 Neutropenia
A38	MEDDRA-PT-ID E9 10029354
A39	CUI E10 C0860207
A40	UMLS-Preferred-Name E10 Drug-Induced Liver Injury
A41	MEDDRA-PT E10 Drug-induced liver injury
A42	MEDDRA-PT-ID E10 10072268
A43	CUI E11 C0151905
A44	UMLS-Preferred-Name E11 Alanine aminotransferase increased
A45	MEDDRA-PT E11 Alanine aminotransferase increased
A46	MEDDRA-PT-ID E11 10001551
A47	LLT E11 ALT increased
A48	LLT-ID E11 10001845
A49	CUI E13 C0151904
A50	UMLS-Preferred-Name E13 Aspartate aminotransferase increased
A51	MEDDRA-PT E13 Aspartate aminotransferase increased
A52	MEDDRA-PT-ID E13 10003481
A53	LLT E13 AST increased
A54	LLT-ID E13 10003544
A55	CUI E14 C0741494
A56	UMLS-Preferred-Name E14 Elevated total bilirubin
A57	MEDDRA-PT E14 Blood bilirubin increased
A58	MEDDRA-PT-ID E14 10005364
A59	LLT E14 Bilirubin total increased
A60	LLT-ID E14 10056806
A61	CUI E16 C0151849
A62	UMLS-Preferred-Name E16 Alkaline phosphatase raised
A63	MEDDRA-PT E16 Blood alkaline phosphatase increased
A64	MEDDRA-PT-ID E16 10059570
A65	LLT E16 Alkaline phosphatase increased
A66	LLT-ID E16 10001675
A67	CUI E18 C0151905
A68	UMLS-Preferred-Name E18 Alanine aminotransferase increased
A69	MEDDRA-PT E18 Alanine aminotransferase increased
A70	MEDDRA-PT-ID E18 10001551
A71	LLT E18 ALT increased
A72	LLT-ID E18 10001845
A73	CUI E19 C0151904
A74	UMLS-Preferred-Name E19 Aspartate aminotransferase increased
A75	MEDDRA-PT E19 Aspartate aminotransferase increased
A76	MEDDRA-PT-ID E19 10003481
A77	LLT E19 AST increased
A78	LLT-ID E19 10003544
A79	CUI E20 C0151904
A80	UMLS-Preferred-Name E20 Aspartate aminotransferase increased
A81	MEDDRA-PT E20 Aspartate aminotransferase increased
A82	MEDDRA-PT-ID E20 10003481
A83	LLT E20 AST increased
A84	LLT-ID E20 10003544
A85	CUI E21 C0151905
A86	UMLS-Preferred-Name E21 Alanine aminotransferase increased
A87	MEDDRA-PT E21 Alanine aminotransferase increased
A88	MEDDRA-PT-ID E21 10001551
A89	LLT E21 ALT increased
A90	LLT-ID E21 10001845
A91	CUI E22 C0438717
A92	UMLS-Preferred-Name E22 Transaminases increased
A93	MEDDRA-PT E22 Transaminases increased
A94	MEDDRA-PT-ID E22 10054889
A95	CUI E23 C0438717
A96	UMLS-Preferred-Name E23 Transaminases increased
A97	MEDDRA-PT E23 Transaminases increased
A98	MEDDRA-PT-ID E23 10054889
A99	CUI E24 C0151905
A100	UMLS-Preferred-Name E24 Alanine aminotransferase increased
A101	MEDDRA-PT E24 Alanine aminotransferase increased
A102	MEDDRA-PT-ID E24 10001551
A103	LLT E24 ALT increased
A104	LLT-ID E24 10001845
A105	CUI E25 C0151904
A106	UMLS-Preferred-Name E25 Aspartate aminotransferase increased
A107	MEDDRA-PT E25 Aspartate aminotransferase increased
A108	MEDDRA-PT-ID E25 10003481
A109	LLT E25 AST increased
A110	LLT-ID E25 10003544
A111	CUI E26 C0268000
A112	UMLS-Preferred-Name E26 Body fluid retention
A113	MEDDRA-PT E26 Fluid retention
A114	MEDDRA-PT-ID E26 10016807
A115	CUI E27 C0031039
A116	UMLS-Preferred-Name E27 Pericardial effusion
A117	MEDDRA-PT E27 Pericardial effusion
A118	MEDDRA-PT-ID E27 10034474
A119	CUI E28 C0032227
A120	UMLS-Preferred-Name E28 Pleural effusion disorder
A121	MEDDRA-PT E28 Pleural effusion
A122	MEDDRA-PT-ID E28 10035598
A123	CUI E30 C0034063
A124	UMLS-Preferred-Name E30 Pulmonary Edema
A125	MEDDRA-PT E30 Pulmonary oedema
A126	MEDDRA-PT-ID E30 10037423
A127	LLT E30 Pulmonary edema
A128	LLT-ID E30 10037375
A129	CUI E31 C0085649
A130	UMLS-Preferred-Name E31 Peripheral edema
A131	MEDDRA-PT E31 Oedema peripheral
A132	MEDDRA-PT-ID E31 10030124
A133	LLT E31 Peripheral edema
A134	LLT-ID E31 10034570
A135	CUI E32 C0268000
A136	UMLS-Preferred-Name E32 Body fluid retention
A137	MEDDRA-PT E32 Fluid retention
A138	MEDDRA-PT-ID E32 10016807
A139	CUI E34 C0032227
A140	UMLS-Preferred-Name E34 Pleural effusion disorder
A141	MEDDRA-PT E34 Pleural effusion
A142	MEDDRA-PT-ID E34 10035598
A143	CUI E37 C0032227
A144	UMLS-Preferred-Name E37 Pleural effusion disorder
A145	MEDDRA-PT E37 Pleural effusion
A146	MEDDRA-PT-ID E37 10035598
A147	CUI E38 C0031039
A148	UMLS-Preferred-Name E38 Pericardial effusion
A149	MEDDRA-PT E38 Pericardial effusion
A150	MEDDRA-PT-ID E38 10034474
A151	CUI E42 C0085649
A152	UMLS-Preferred-Name E42 Peripheral edema
A153	MEDDRA-PT E42 Oedema peripheral
A154	MEDDRA-PT-ID E42 10030124
A155	LLT E42 Peripheral edema
A156	LLT-ID E42 10034570
A157	CUI E43 C0034063
A158	UMLS-Preferred-Name E43 Pulmonary Edema
A159	MEDDRA-PT E43 Pulmonary oedema
A160	MEDDRA-PT-ID E43 10037423
A161	LLT E43 Pulmonary edema
A162	LLT-ID E43 10037375
A163	CUI E44 C0013604
A164	UMLS-Preferred-Name E44 Edema
A165	MEDDRA-PT E44 Oedema
A166	MEDDRA-PT-ID E44 10030095
A167	LLT E44 Edema
A168	LLT-ID E44 10014210
A169	CUI E46 C0853068
A170	UMLS-Preferred-Name E46 Decreased glomerular filtration rate
A171	MEDDRA-PT E46 Glomerular filtration rate decreased
A172	MEDDRA-PT-ID E46 10018358
A173	CUI E62 C0035078
A174	UMLS-Preferred-Name E62 Kidney Failure
A175	MEDDRA-PT E62 Renal failure
A176	MEDDRA-PT-ID E62 10038435
A177	LLT E62 Kidney failure
A178	LLT-ID E62 10023418
A179	CUI E63 C0854268
A180	UMLS-Preferred-Name E63 Foetal damage
A181	MEDDRA-PT E63 Foetal damage
A182	MEDDRA-PT-ID E63 10016852
A183	LLT E63 Fetal damage
A184	LLT-ID E63 10054743
A185	CUI E65 C0270009
A186	UMLS-Preferred-Name E65 Fetal or neonatal effect of toxic substance transmitted via placenta and/or breast milk
A187	MEDDRA-PT E65 Maternal drugs affecting foetus
A188	MEDDRA-PT-ID E65 10026923
A189	LLT E65 Drug toxicity NEC affecting foetus
A190	LLT-ID E65 10013750
A191	CUI E67 C1142499
A192	UMLS-Preferred-Name E67 Gastrointestinal toxicity
A193	MEDDRA-PT E67 Gastrointestinal toxicity
A194	MEDDRA-PT-ID E67 10059024
A195	CUI E68 C0854467
A196	UMLS-Preferred-Name E68 Myelosuppression
A197	MEDDRA-PT E68 Bone marrow failure
A198	MEDDRA-PT-ID E68 10065553
A199	LLT E68 Myelosuppression
A200	LLT-ID E68 10028584
A201	CUI E69 C0348754
A202	UMLS-Preferred-Name E69 Toxic liver disease
A203	MEDDRA-PT E69 Hepatotoxicity
A204	MEDDRA-PT-ID E69 10019851
A205	CUI E70 C0268000
A206	UMLS-Preferred-Name E70 Body fluid retention
A207	MEDDRA-PT E70 Fluid retention
A208	MEDDRA-PT-ID E70 10016807
A209	CUI E71 C0595916
A210	UMLS-Preferred-Name E71 Toxic nephropathy
A211	MEDDRA-PT E71 Nephropathy toxic
A212	MEDDRA-PT-ID E71 10029155
A213	LLT E71 Toxicity renal
A214	LLT-ID E71 10044258
A215	CUI E15 C0270009
A216	UMLS-Preferred-Name E15 Fetal or neonatal effect of toxic substance transmitted via placenta and/or breast milk
A217	MEDDRA-PT E15 Maternal drugs affecting foetus
A218	MEDDRA-PT-ID E15 10026923
A219	LLT E15 Drug toxicity NEC affecting foetus
A220	LLT-ID E15 10013750
